WESTON, Fla., June 3, 2026 /PRNewswire/ - Apotex Corp. ("Apotex") today announced the U.S. launch of sitagliptin tablets and sitagliptin and metformin hydrochloride tablets, both of which are eligible ...

Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are not adequately controlled on metformin or sitagliptin alone or in patients already being treated with ...

Results from a study involving adding sitagliptin and increasing doses of metformin for patients who cannot attain glycemic control show that as glycated hemoglobin increases, it becomes harder to ...

Please provide your email address to receive an email when new articles are posted on . “Clinical practice guidelines recommend adding second-line agents, such as DPP-IV inhibitors, if glycemic ...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a late-breaking observational study that assessed the differences in time to initiation of insulin ...

With the two active components, sitagliptin and metformin, Janumet has a comprehensive mechanism of action that targets all three key defects of T2DM for improved glycemic control: diminished insulin ...

Do not use if you have ever had an allergic reaction to SITAGLIPTIN/METFORMIN MYLAN or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions ...

The study assessed the safety and efficacy of adding JANUVIA (sitagliptin) 100 mg once-daily or dapagliflozin 10 mg once-daily to treatment of patients with mild renal impairment (eGFR ≥60 and <90 ...

Expert Rev Endocrinol Metab. 2008;3(6):691-697. Elimination of sitagliptin occurs primarily via renal excretion (79%) and involves active tubular secretion. Sitagliptin is a substrate for human ...

NEW ORLEANS -- Once-daily oral semaglutide showed greater effect for reducing HbA1c versus sitagliptin (Januvia) in patients with type 2 diabetes uncontrolled with metformin, with or without ...

Results of the study demonstrated that therapy with ONGLYZA 5 mg was non-inferior to JANUVIA 100 mg when added to metformin (difference in adjusted mean change from baseline vs. JANUVIA plus metformin ...